作者:Drew Rutherford、David A. Atwood
DOI:10.1021/om9603631
日期:1996.10.15
ine)) (2), Salophen (N,N‘-benzenylidenebis(3,5-di-tert-butylsalicylideneamine)) (3), and Salomphen (N,N‘-(3,4-dimethylbenzenylidene)bis(3,5-di-tert-butylsalicylideneimine)) (4)) and the novel five-coordinate monomeric amides of formula LAlNRR‘ (where L = Acen (N,N‘-ethylenebis((tBu)salicylidene(methyl)imine); R, R‘ = H, Ph (5); R = R‘ = SiMe3 (6)) and L = Salen (R, R‘ = H, tBu (7), H, Ph (8), and H
在本手稿中,我们将详细介绍Salen(t Bu)H 2配体与第13组元素的首次使用。这包括分子式为Salen(t Bu)AlCl的化合物(其中Salen = Salen(N,N'-乙撑双(3,5-二叔丁基水杨酰亚胺))(1),Salpen(N,N'-丙撑双(3) ,5-二叔丁基水杨亚胺))(2),Salophen(N,N'-苯二亚甲基双(3,5-二叔丁基水杨亚胺))(3)和Salomphen(N,N'-(3,4-二甲基苯亚甲基)双(3,5-二叔丁基水杨亚胺)(4))和式LAlNRR'的新型五配位单体酰胺(其中L = Acen(N,N'-亚乙基双( (t Bu)水杨基(甲基)亚胺); R,R'= H,Ph(5); R = R'= SiMe 3(6))和L = Salen(R,R'= H,t Bu(7)),H,Ph(8)和H,Dipp(2,6-二异丙基苯基)(9); R = R'= Me(10),Et(11)和SiMe